These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 28101965)

  • 21. Immunoadsorber for specific apheresis of autoantibodies in the treatment of bullous pemphigoid.
    Mersmann M; Dworschak J; Ebermann K; Komorowski L; Schlumberger W; Stöcker W; Zillikens D; Probst C; Schmidt E
    Arch Dermatol Res; 2016 Jan; 308(1):31-8. PubMed ID: 26498290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Checkpoint Inhibition May Trigger the Rare Variant of Anti-LAD-1 IgG-Positive, Anti-BP180 NC16A IgG-Negative Bullous Pemphigoid.
    Sadik CD; Langan EA; Grätz V; Zillikens D; Terheyden P
    Front Immunol; 2019; 10():1934. PubMed ID: 31474998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and Immunological Profiles of 14 Patients With Bullous Pemphigoid Without IgG Autoantibodies to the BP180 NC16A Domain.
    Nakama K; Koga H; Ishii N; Ohata C; Hashimoto T; Nakama T
    JAMA Dermatol; 2018 Mar; 154(3):347-350. PubMed ID: 29299596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IgG antibodies against immunodominant C-terminal epitopes of BP230 do not induce skin blistering in mice.
    Feldrihan V; Licarete E; Florea F; Cristea V; Popescu O; Sitaru C; Chiriac MT
    Hum Immunol; 2014 Apr; 75(4):354-63. PubMed ID: 24468586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoreactive T and B cells from bullous pemphigoid (BP) patients recognize epitopes clustered in distinct regions of BP180 and BP230.
    Thoma-Uszynski S; Uter W; Schwietzke S; Schuler G; Borradori L; Hertl M
    J Immunol; 2006 Feb; 176(3):2015-23. PubMed ID: 16424234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurological and psychiatric associations in bullous pemphigoid-more than skin deep?
    Försti AK; Huilaja L; Schmidt E; Tasanen K
    Exp Dermatol; 2017 Dec; 26(12):1228-1234. PubMed ID: 28677172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reactivity against the BP180 ectodomain in patients with bullous pemphigoid, mucous membrane pemphigoid, multiple sclerosis and Parkinson disease.
    Tegtmeyer J; Romagnuolo M; Hammers CM; Opelka B; Probst C; Komorowski L; Marzano AV; Schmidt E; Goletz S
    Exp Dermatol; 2024 Jul; 33(7):e15125. PubMed ID: 38946225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tight clustering of extracellular BP180 epitopes recognized by bullous pemphigoid autoantibodies.
    Zillikens D; Rose PA; Balding SD; Liu Z; Olague-Marchan M; Diaz LA; Giudice GJ
    J Invest Dermatol; 1997 Oct; 109(4):573-9. PubMed ID: 9326393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IgG autoantibody reactivity against bullous pemphigoid (BP) 180 and BP230 in elderly patients with pruritic dermatoses.
    Feliciani C; Caldarola G; Kneisel A; Podstawa E; Pfütze M; Pfützner W; Hertl M
    Br J Dermatol; 2009 Aug; 161(2):306-12. PubMed ID: 19485996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Missing the target: characterization of bullous pemphigoid patients who are negative using the BP180 enzyme-linked immunosorbant assay.
    Fairley JA; Bream M; Fullenkamp C; Syrbu S; Chen M; Messingham KN
    J Am Acad Dermatol; 2013 Mar; 68(3):395-403. PubMed ID: 23083837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective study in bullous pemphigoid: association of high serum anti-BP180 IgG levels with increased mortality and reduced Karnofsky score.
    Holtsche MM; Goletz S; van Beek N; Zillikens D; Benoit S; Harman K; Walton S; English J; Sticherling M; Chapman A; Levell NJ; Groves R; Williams HC; König IR; Schmidt E;
    Br J Dermatol; 2018 Oct; 179(4):918-924. PubMed ID: 29607480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Levels of anti-BP180 NC16A IgE do not correlate with severity of disease in the early stages of bullous pemphigoid.
    Bing L; Xiping Z; Li L; Jun P; Yi-Xia W; Min Y; Qing L; Qiu-Ning S; Hong-Zhong J; Ya-Gang Z
    Arch Dermatol Res; 2015 Nov; 307(9):849-54. PubMed ID: 26404084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-BP230 IgE autoantibodies in bullous pemphigoid intraindividually correlate with disease activity.
    Emtenani S; Linnemann BE; Recke A; von Georg A; Goletz S; Schmidt E; van Beek N
    J Dermatol Sci; 2024 May; 114(2):64-70. PubMed ID: 38582700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoantibodies Against the Immunodominant Bullous Pemphigoid Epitopes Are Rare in Patients With Dermatitis Herpetiformis and Coeliac Disease.
    Nätynki A; Tuusa J; Hervonen K; Kaukinen K; Lindgren O; Huilaja L; Kokkonen N; Salmi T; Tasanen K
    Front Immunol; 2020; 11():575805. PubMed ID: 33072118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymorphisms in the Mitochondrial Genome Are Associated With Bullous Pemphigoid in Germans.
    Russlies J; Fähnrich A; Witte M; Yin J; Benoit S; Gläser R; Günter C; Eming R; Erdmann J; Gola D; Gupta Y; Holtsche MM; Kern JS; König IR; Kiritsi D; Lieb W; Sadik CD; Sárdy M; Schauer F; van Beek N; Weidinger A; Worm M; Zillikens D; Schmidt E; Busch H; Ibrahim SM; Hirose M
    Front Immunol; 2019; 10():2200. PubMed ID: 31824475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mapping the binding sites of anti-BP180 immunoglobulin E autoantibodies in bullous pemphigoid.
    Fairley JA; Fu CL; Giudice GJ
    J Invest Dermatol; 2005 Sep; 125(3):467-72. PubMed ID: 16117787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristics of IgG subclasses and complement deposition in BP230-type bullous pemphigoid.
    Zheng M; Ujiie H; Iwata H; Muramatsu K; Yoshimoto N; Ito T; Ujiie I; Shimizu S; Sato-Matsumura KC; Shimizu H
    J Eur Acad Dermatol Venereol; 2019 Mar; 33(3):595-600. PubMed ID: 30394605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of autoantibodies against BP180/BP230 in response to topical corticosteroids in patients with bullous pemphigoid.
    Schneiderbauer R; Martinache S; Engstner M; Enk AH; Hadaschik EN
    Dermatol Ther; 2016 Nov; 29(6):419-423. PubMed ID: 27550573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bullous pemphigoid and cicatricial pemphigoid autoantibodies react with ultrastructurally separable epitopes on the BP180 ectodomain: evidence that BP180 spans the lamina lucida.
    Bédane C; McMillan JR; Balding SD; Bernard P; Prost C; Bonnetblanc JM; Diaz LA; Eady RA; Giudice GJ
    J Invest Dermatol; 1997 Jun; 108(6):901-7. PubMed ID: 9182819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usefulness of BP230 and BP180-NC16a enzyme-linked immunosorbent assays in the initial diagnosis of bullous pemphigoid: a retrospective study of 138 patients.
    Charneux J; Lorin J; Vitry F; Antonicelli F; Reguiai Z; Barbe C; Tabary T; Grange F; Bernard P
    Arch Dermatol; 2011 Mar; 147(3):286-91. PubMed ID: 21422334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.